Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood

European Journal of Pediatrics

Volumn 158, Issue 4, 1999, Pages 284-287

  Verhoef, S ^a   Van Diemen Steenvoorde, R ^b   Akkersdijk, W L ^c   Bax, N M A ^c   Ariyurek, Y ^a   Hermans, C J ^a   Van Nieuwenhuizen, O ^c   Nikkels, P G J ^d   Lindhout, D ^a   Halley, D J J ^a   Lips, K ^d   Van Den Ouweland, A M W ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Islet cell tumour; Loss of heterozygosity; Pancreas; TSC2 gene; Tuberous sclerosis complex

Indexed keywords

PANCREAS HORMONE;

ANGIOMYOLIPOMA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CHILDHOOD DISEASE; CHROMOSOME 16; CLINICAL FEATURE; DISEASE ASSOCIATION; EPILEPSY; EXON; GENE MUTATION; HEMANGIOFIBROMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; LYMPH NODE METASTASIS; MALE; MENTAL DEFICIENCY; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; RETROPERITONEUM; SCHOOL CHILD; TUBEROUS SCLEROSIS;

CARCINOMA, ISLET CELL; CHILD; CHROMOSOMES, HUMAN, PAIR 16; HUMANS; LOSS OF HETEROZYGOSITY; MALE; PANCREATIC NEOPLASMS; TUBEROUS SCLEROSIS;

EID: 0032913859     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051073     Document Type: Article

References (15)

1. 1. Davoren PM, Epstein MT (1992) Insulinoma complicating tuberous sclerosis. J Neurol Neurosurg Psychiatr 55:1209
2. 2. The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315
3. 3. Gomez MR (1988) "Tuberous sclerosis." 2nd edn. Raven Press, New York
4. 4. Gomez MR (1991) Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci 615:1-7
5. 5. Green AJ, Smith M, Yates JRW (1994) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193-196
6. 6. Hulst KL van, Hoppener JWM, Berends MHJ, et al (1994) Characterization of antibodies against human islet amyloid polypeptide (IAPP/amylin) and its C-terminal flanking polypeptide (C-proIAPP). Eur J Endocrinol 130 [Suppl 2]:196
7. 7. Kim H, Kerr A, Morehouse H (1995) The association between tuberous sclerosis and insulinoma. Am J Neuroradiol 16:1543-1544
8. 8. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 68: 820-823
9. 9. Orimoto K, Tsuchiya H, Kobayashi T, Matsuda T, Hino O (1996) Suppression of the neoplastic phenotype by replacement of the TSC2 gene in Eker rat renal carcinoma cells. Biochem Biophys Res Comm 219:70-75
10. 10. Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125-127
11. 11. Schwarzkopf G, Pfisterer J (1993): Metastasierendes Gastrinom und der Tuberoese Sklerose Komplex. Zentralbl Pathol 139:477-481
12. 12. Slegtenhorst M van, Hoogt R de, Hermans C, et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808
13. 13. Slegtenhorst M van, Nellist M, Nagelkerken B, et al (1998): Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Gen 7:1053-1057
14. 14. Verbeek BS, Vroom TM, Adriaansen-Slot SS, et al (1996) C-SRC protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180:383-388
15. 15. Verhoef S, Vrtel R, Bakker L, Stolte-Dijkstra I, Nellist M, Begeer JH, Zaremba J, Jozwiak S, Tempelaars AMP, Lindhout D, Halley DJJ, Ouweland AMW van den (1998) Recurrent mutation 4882delTT in the GAP-related domain of the tuberous sclerosis TSC2 gene. Hum Mutat [Suppl1]:S85-S87